Tech Company Financing Transactions
OliX Pharmaceuticals Funding Round
L'Oreal BOLD Ventures and Weiss Asset Management invested in a $71 million funding round for OliX Pharmaceuticals. The round was announced on 6/4/2026.
Transaction Overview
Company Name
Announced On
6/4/2026
Transaction Type
Venture Equity
Amount
$71,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
953, Daewangpangyo-ro, Sujeong-gu
Seongnam-si, Gyeonggi-do, 13106
Republic of Korea
Seongnam-si, Gyeonggi-do, 13106
Republic of Korea
Phone
Website
Email Address
Not Recorded
Overview
MISSION: To contribute to the health and happiness of mankind using cutting-edge technology. VISION: We establish technological excellence through approved RNAi therapeutics and lead the paradigm shift by 2030. A globally recognized leader in RNA therapeutics, driven by platform innovation and validated global partnerships; A premier research institution that sets new benchmarks in drug innovation through the sustainable growth of talent and technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dong Lee
President
Chung Kang
VP - Bus. Development
Shin Park
VP - Finance
Young Kim
VP - General Counsel
Young Baek
VP - R & D
June Park
Browse more venture capital transactions:
Prev: 6/4/2026: Semble venture capital transaction
Next: 6/4/2026: MediElaj venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to record all VC transactions involving tech companies. All VC database entries reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs